Literature DB >> 26194402

Risk of persistent steroid dependency after switching from cyclosporine to mycophenolate mofetil in children with idiopathic nephrotic syndrome.

Shuichiro Fujinaga1, Daishi Hirano2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26194402     DOI： 10.1007/s00467-015-3163-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial.

Authors:  Kenji Ishikura; Norishige Yoshikawa; Hitoshi Nakazato; Satoshi Sasaki; Koichi Nakanishi; Takeshi Matsuyama; Shuichi Ito; Yuko Hamasaki; Nahoko Yata; Takashi Ando; Kazumoto Iijima; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2014-10-03       Impact factor: 3.714

2.  Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil.

Authors:  Sushmita Banerjee; Amitava Pahari; Jayati Sengupta; Saroj K Patnaik
Journal:  Pediatr Nephrol       Date:  2012-08-14       Impact factor: 3.714

3.  Two-year follow-up of a prospective clinical trial of cyclosporine for frequently relapsing nephrotic syndrome in children.

Authors:  Kenji Ishikura; Norishige Yoshikawa; Hitoshi Nakazato; Satoshi Sasaki; Kazumoto Iijima; Koichi Nakanishi; Takeshi Matsuyama; Shuichi Ito; Nahoko Yata; Takashi Ando; Masataka Honda
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-26       Impact factor: 8.237
  3 in total
  1 in total

Review 1.  Progress in pediatrics in 2015: choices in allergy, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, nephrology, neurology, nutrition, oncology and pulmonology.

Authors:  Carlo Caffarelli; Francesca Santamaria; Dora Di Mauro; Carla Mastrorilli; Virginia Mirra; Sergio Bernasconi
Journal:  Ital J Pediatr       Date:  2016-08-27       Impact factor: 2.638
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.